Aspire Biopharma Holdings Inc. (ASBP)
NASDAQ · Healthcare
Aspire Biopharma Holdings Inc. annual/quarterly total liabilities history from 2025 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aspire Biopharma Holdings Inc. total liabilities for the quarter ending December 31, 2025 were 7.7M.
- Aspire Biopharma Holdings Inc. total liabilities for 2025 were 7.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aspire Biopharma Holdings Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $8 |
| Aspire Biopharma Holdings Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $8 |
Aspire Biopharma Holdings Inc. Total Liabilities — FAQ
Aspire Biopharma Holdings Inc. (ASBP) total liabilities over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ASBP's total liabilities history?
The chart and table above show Aspire Biopharma Holdings Inc.'s total liabilities by year and by quarter, including the growth rate.